Fingerprint
Dive into the research topics of 'Phase III study of selpercatinib versus chemotherapy ± pembrolizumab in untreated RET positive non-small-cell lung cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase III study of selpercatinib versus chemotherapy ± pembrolizumab in untreated RET positive non-small-cell lung cancer
Benjamin J. Solomon, Cai Cun Zhou, Alexander Drilon, Keunchil Park, Jürgen Wolf, Yasir Elamin, Hannah M. Davis, Victoria Soldatenkova, Andreas Sashegyi, Aimee Bence Lin, Boris K. Lin, Herbert H.F. Loong, Silvia Novello, Edurne Arriola, Maurice Pérol, Koichi Goto, Fernando C. Santini
Research output: Contribution to journal › Article › peer-review
28
Scopus
citations